the unique attomarker platform
Attomarker Technology Overview
Attomarker technology is a label-free particle plasmon resonance multiplexed array that can measure the concentration quantitatively for up to 20 species in 10 µL blood sample in 7 minutes. The original idea came from a proposal to the Engineering and Physical Sciences Research Council of the UK to profile patient blood rapidly, not just for a single marker but for a panel of markers allowing the person’s clinical condition to be treated as a system evolving in time.
Attomarker technology is an array of gold nanoparticles illuminated in total-internal-reflection and monitored in real time by a video camera, Figure 1. The spots are functionalised with proteins or antibodies specific that provide the specificity for the target assays, as well as a set of control spots and calibrations to ensure a quantitative result.
LISCAR 6 Benchtop
The LISCAR 6 platform is a benchtop instrument incorporating the Attomarker technology and designed for use at the point-of-care in clinics, hospital and pharmacies. It is adaptable and can perform a different rapid, multiplexed biomarker test each day, depending on which type of test chip is inserted. Consequently, in the near future, the Liscar 6 instrument will be able to perform tests for liver function testing for management of type 2 diabetes and fatty liver disease, fertility & menstrual cycle monitoring, and allergy screening, to name a few, allowing clinics to either use multiple machines every day or to use a single machine with specific testing assigned to a day, according to clinic needs and patient throughput.
Attomarker is also currently developing a handheld version of the device with the same tests, targeting launch in early 2023.
Available early 2023
Handheld
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
